Company intelligence
Shockwave Medical
About Shockwave Medical
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL
Verified activity
Signals from Shockwave Medical
9 published signals
Presence & Recognition
Shockwave Medical announced that the Shockwave IVL Experience Center is in full swing at CIRSE 2026 with a Fem-Pop session scheduled for 11:00.
Reported by Shockwave Medical
Presence & Recognition
Shockwave Medical presented acute procedural data from the CALCIO study at CIRSE 2026, providing early insights into the use of Shockwave IVL in a complex population with fem-pop and crural calcified lesions.
Reported by Shockwave Medical
Presence & Recognition
Shockwave Medical is part of cases that help physicians address complex coronary calcified lesions.
Reported by Shockwave Medical
Products & Services
Shockwave Medical delivers Shockwave C2 Aero for treating challenging calcified nodules.
Reported by Shockwave Medical
Customers & Market
Shockwave Medical completed Canada's first Shockwave C2 Aero case at St. Boniface Hospital.
Reported by Shockwave Medical
Presence & Recognition
Shockwave Medical is exhibiting at the CIRSE 2026 booth D22 with the Shockwave IVL Experience Center.
Reported by Shockwave Medical
Research & Knowledge
Shockwave Medical published results from a real-world study of the ShockwaveReducer in UK hospitals over a 10-year period published by Drs. Ranil De Silva and Kevin Cheng at the Royal Brompton and Harefield hospitals and Imperial College London.
Reported by Shockwave Medical
Research & Knowledge
Shockwave Medical published a Vascular News supplement examining the evolving role of Shockwave IVL in the treatment of complex calcified lesions, highlighting calcium modification and endovascular intervention in peripheral lesions.
Reported by Shockwave Medical
Products & Services
Shockwave Medical launched version 1 of BizMath, an iOS app designed to help job candidates in consulting and finance prepare for mental math interviews.
Reported by Erika Wilcox